Balloon-expanding transcatheter aortic valve implantation for degenerated Mitroflow bioprostheses: clinical and echocardiographic long-term outcomes.
Victor X MosqueraAlberto Bouzas-MosqueraYago Vilela-GonzálezCarlos VelascoJorge Salgado-FernándezRamón Calviño-SantosNicolás Vázquez-GonzálezJosé M Vázquez-RodríguezJosé M Herrera-NoreñaPublished in: Interactive cardiovascular and thoracic surgery (2021)
Valve-in-valve procedures with balloon-expandable transcatheter valves associate a high risk of coronary occlusion in patients with indexed aortic root diameter <14 mm/m2 and low coronary ostia <12 mm. Valve-in valve procedures with 20 mm balloon-expandable transcatheter valves in ≤21 mm Mitroflow bioprosthesis leave significant residual transvalvular gradients that might obscure patients' long-term outcomes.
Keyphrases
- aortic valve
- aortic stenosis
- transcatheter aortic valve implantation
- aortic valve replacement
- ejection fraction
- transcatheter aortic valve replacement
- left ventricular
- end stage renal disease
- coronary artery
- coronary artery disease
- mitral valve
- newly diagnosed
- chronic kidney disease
- prognostic factors
- pulmonary hypertension
- peritoneal dialysis
- pulmonary artery
- patient reported outcomes